Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2001 Aug;77(4):276–282. doi: 10.1136/sti.77.4.276

Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens

I G M van Valkengoed 1, M Postma 1, S Morre 1, A J C van den Brule 1, C Meijer 1, L Bouter 1, A Boeke 1
PMCID: PMC1744325  PMID: 11463928

Abstract

Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic Chlamydia trachomatis infections in a female inner city population. To determine the sensitivity of the cost effectiveness analysis to variation in the probability of developing sequelae.

Methods: A decision tree was constructed to evaluate health effects of the programme, such as averted sequelae of chlamydial infection. Cost effectiveness from a societal perspective was estimated for screening by means of a ligase chain reaction on mailed, home obtained urine specimens, in a population with a C trachomatis test prevalence of 2.9%. An extensive sensitivity analysis was performed for the probability of sequelae, the percentage of preventable pelvic inflammatory disease (PID), and the discount rate.

Results: The estimated net cost of curing one woman, aged 15–40 years, of a C trachomatis infection is US$1210. To prevent one major outcome (PID, tubal factor infertility, ectopic pregnancy, chronic pelvic pain, or neonatal pneumonia), 479 women would have to be screened. The net cost of preventing one major outcome is $15 800. Changing the probability of PID after chlamydial infection from 5% to 25% decreases the net cost per major outcome averted from $28 300 to $6380, a reduction of 78%. Results were less sensitive to variations in estimates for other sequelae. The breakeven prevalence of the programme ranges from 6.4% for the scenario with all probabilities for complications set at the maximum value to a prevalence of 100% for probabilities set at the minimum value.

Conclusions: Systematic screening of all women aged 15–40 years for asymptomatic C trachomatis infections is not cost effective. Although the results of the analyses are sensitive to variation in the assumptions, the costs exceed the benefits, even in the most optimistic scenario.

Key Words: cost effectiveness analysis; Chlamydia trachomatis; screening

Full Text

The Full Text of this article is available as a PDF (176.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brunham R. C., Binns B., McDowell J., Paraskevas M. Chlamydia trachomatis infection in women with ectopic pregnancy. Obstet Gynecol. 1986 May;67(5):722–726. doi: 10.1097/00006250-198605000-00022. [DOI] [PubMed] [Google Scholar]
  2. Buhaug H., Skjeldestad F. E., Halvorsen L. E., Dalen A. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract. 1990 Apr;40(333):142–145. [PMC free article] [PubMed] [Google Scholar]
  3. Duncan B., Hart G. Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ. 1999 Apr 3;318(7188):931–933. doi: 10.1136/bmj.318.7188.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Genç M., Ruusuvaara L., Mårdh P. A. An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA. 1993 Nov 3;270(17):2057–2064. doi: 10.1001/jama.1993.03510170047029. [DOI] [PubMed] [Google Scholar]
  5. Grun L., Tassano-Smith J., Carder C., Johnson A. M., Robinson A., Murray E., Stephenson J., Haines A., Copas A., Ridgway G. Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ. 1997 Jul 26;315(7102):226–230. doi: 10.1136/bmj.315.7102.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howell M. R., Quinn T. C., Gaydos C. A. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med. 1998 Feb 15;128(4):277–284. doi: 10.7326/0003-4819-128-4-199802150-00005. [DOI] [PubMed] [Google Scholar]
  7. Kamwendo F., Forslin L., Bodin L., Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden. Sex Transm Dis. 1996 Sep-Oct;23(5):384–391. doi: 10.1097/00007435-199609000-00007. [DOI] [PubMed] [Google Scholar]
  8. Marrazzo J. M., Celum C. L., Hillis S. D., Fine D., DeLisle S., Handsfield H. H. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis. 1997 Mar;24(3):131–141. doi: 10.1097/00007435-199703000-00003. [DOI] [PubMed] [Google Scholar]
  9. Morré S. A., van Valkengoed I. G., de Jong A., Boeke A. J., van Eijk J. T., Meijer C. J., van den Brule A. J. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J Clin Microbiol. 1999 Apr;37(4):976–980. doi: 10.1128/jcm.37.4.976-980.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mouton J. W., Verkooyen R., van der Meijden W. I., van Rijsoort-Vos T. H., Goessens W. H., Kluytmans J. A., Deelen S. D., Luijendijk A., Verbrugh H. A. Detection of Chlamydia trachomatis in male and female urine specimens by using the amplified Chlamydia trachomatis test. J Clin Microbiol. 1997 Jun;35(6):1369–1372. doi: 10.1128/jcm.35.6.1369-1372.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ostergaard L., Møller J. K., Andersen B., Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ. 1996 Nov 9;313(7066):1186–1189. doi: 10.1136/bmj.313.7066.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Parsonage M., Neuburger H. Discounting and health benefits. Health Econ. 1992 Apr;1(1):71–76. doi: 10.1002/hec.4730010110. [DOI] [PubMed] [Google Scholar]
  13. Postma M. J., Bos J. M., van Gennep M., Jager J. C., Baltussen R., Sprenger M. J. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Pharmacoeconomics. 1999;16 (Suppl 1):33–40. doi: 10.2165/00019053-199916001-00005. [DOI] [PubMed] [Google Scholar]
  14. Postma M. J., Welte R., van den Hoek J. A., van Doornum G. J., Coutinho R. A., Jager J. C. Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking in Amsterdam. II. Kosteneffectiviteitsanalyse van screening bij vrouwen. Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):677–681. [PubMed] [Google Scholar]
  15. Schachter J., Grossman M., Sweet R. L., Holt J., Jordan C., Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA. 1986 Jun 27;255(24):3374–3377. [PubMed] [Google Scholar]
  16. Scholes D., Stergachis A., Heidrich F. E., Andrilla H., Holmes K. K., Stamm W. E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362–1366. doi: 10.1056/NEJM199605233342103. [DOI] [PubMed] [Google Scholar]
  17. Sellors J. W., Mahony J. B., Chernesky M. A., Rath D. J. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril. 1988 Mar;49(3):451–457. doi: 10.1016/s0015-0282(16)59772-6. [DOI] [PubMed] [Google Scholar]
  18. Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):880–892. doi: 10.1016/0002-9378(80)91077-7. [DOI] [PubMed] [Google Scholar]
  19. Weström L., Joesoef R., Reynolds G., Hagdu A., Thompson S. E. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992 Jul-Aug;19(4):185–192. [PubMed] [Google Scholar]
  20. van Doornum G. J., Buimer M., Prins M., Henquet C. J., Coutinho R. A., Plier P. K., Tomazic-Allen S., Hu H., Lee H. Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol. 1995 Aug;33(8):2042–2047. doi: 10.1128/jcm.33.8.2042-2047.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. van Valkengoed I. G., Morré S. A., van den Brule A. J., Meijer C. J., Devillé W., Bouter L. M., Boeke A. J. Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population. Sex Transm Infect. 2000 Oct;76(5):375–380. doi: 10.1136/sti.76.5.375. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES